Chemistry:NDTDI

Short description: Chemical compound

NDTDI

Legal status
Legal status	Illegal in Latvia
Identifiers
IUPAC name N,N-diethyl-3-(methyl(1,3,4,5-tetrahydrobenzo[cd]indol-4-yl)amino)propanamide
PubChem CID	163192742
Chemical and physical data
Formula	C19H27N3O
Molar mass	313.445 g·mol−1
3D model (JSmol)	Interactive image
SMILES CCN(CC)C(=O)CCN(C)C1Cc3cccc2ncc(C1)c23

NDTDI is a tricyclic tryptamine derivative which is thought to act as a serotonin receptor agonist, though its pharmacology has not been studied in detail. It is a structurally simplified analogue of LSD and is reported to retain similar effects, though with many times lower potency. It has been sold as a designer drug since 2016 and was first identified by a forensic laboratory in Slovenia in 2017.

Legality

NDTDI was made illegal in Latvia in March 2017.

See also

• 4,5-DHP-DMT
• Bay R 1531
• RU-28306
• RU-24,969